Please login to the form below

Not currently logged in
Email:
Password:

South Africa to develop HIV, TB and malaria vaccines

South Africa's President, Thabo Mbeki, opens the third branch of the International Centre for Genetic Engineering and Biotechnology in Cape Town

South Africa's President, Thabo Mbeki, has opened the third branch of the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Cape Town, according to local media reports.

The centre will conduct vaccine R&D for HIV, malaria, tuberculosis and other infectious diseases affecting the country.

South Africa has spent ZAR 40m (USD 5.6m) on the ICGEB lab, which is located at the University of Cape Town's Institute of Infectious Diseases and Molecular Medicine.

As South Africa's funds were only sufficient to establish three research groups, President Mbeki challenged the international community to donate up to ZAR 120m (USD 17m), which would help to fund seven research programmes slated for a 2010 launch.

Mbeki also invited potential partners to assist and work with the ICGEB to ensure that it realised its objectives.

Nigeria and Tanzania lost out in competitive bids to host the African branch of ICGEB. The other ICGEB sites are located in Trieste, Italy, and New Delhi, India.

30th September 2008

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Is communication failing us?
Compelling people to care in a world oversaturated with news and information...
Are your field teams ready to excel in the new era?
A qualitative research approach to help you critically assess post-pandemic learnings and ignite the potential of meaningful interactions with HCPs....
5 Healthcare Marketing Blunders | How To Avoid Them.
Here are 5 healthcare marketing blunders and how best to avoid them....